Published in Lab Business Week, December 2nd, 2007
For the first quarter of fiscal 2008, net sales were $17.5 million compared with $22.0 million for the same period of the prior year. Net loss was $127,000, or $0.01 per share versus net income of $1.3 million, or $0.05 per basic and diluted share, for the first quarter of fiscal 2007.
"Expenses associated with operating our acquired raw material and oral solutions supplier weighed on our bottom-line results," said Arthur Bedrosian, president and chief executive officer of Lannett. "Excluding this unit's operating expenses, our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week